Clinical Trials & Research

20285 - Ph2 Dara Lena Dexa (DRd) MM I

A phase II trial of daratumumab, lenalidomide and dexamethasone (DRd) in combination with selinexor for patients with newly diagnosed multiple myeloma (USOR 20285)

Disease Types: Multiple Myeloma,&nbs

Available at: {clinical_trial_location backspace="7"} 20285 - Ph2 Dara Lena Dexa (DRd) MM I, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}